These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37744404)

  • 1.
    Volpedo G; Pacheco-Fernandez T; Oljuskin T; Markle HL; Azodi N; Hamano S; Matlashewski G; Gannavaram S; Nakhasi HL; Satoskar AR
    iScience; 2023 Sep; 26(9):107594. PubMed ID: 37744404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrin-deficient Leishmania mexicana confers protection against New World cutaneous leishmaniasis.
    Volpedo G; Pacheco-Fernandez T; Holcomb EA; Zhang WW; Lypaczewski P; Cox B; Fultz R; Mishan C; Verma C; Huston RH; Wharton AR; Dey R; Karmakar S; Oghumu S; Hamano S; Gannavaram S; Nakhasi HL; Matlashewski G; Satoskar AR
    NPJ Vaccines; 2022 Mar; 7(1):32. PubMed ID: 35236861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis.
    Karmakar S; Volpedo G; Zhang WW; Lypaczewski P; Ismail N; Oliveira F; Oristian J; Meneses C; Gannavaram S; Kamhawi S; Hamano S; Valenzuela JG; Matlashewski G; Satoskar AR; Dey R; Nakhasi HL
    NPJ Vaccines; 2022 Dec; 7(1):157. PubMed ID: 36463228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana.
    Dey R; Natarajan G; Bhattacharya P; Cummings H; Dagur PK; Terrazas C; Selvapandiyan A; McCoy JP; Duncan R; Satoskar AR; Nakhasi HL
    J Immunol; 2014 Oct; 193(7):3513-27. PubMed ID: 25156362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Oljuskin T; Azodi N; Volpedo G; Bhattacharya P; Markle HL; Hamano S; Matlashewski G; Satoskar AR; Gannavaram S; Nakhasi HL
    iScience; 2023 Sep; 26(9):107593. PubMed ID: 37744403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live Attenuated
    Banerjee A; Bhattacharya P; Dagur PK; Karmakar S; Ismail N; Joshi AB; Akue AD; KuKuruga M; McCoy JP; Dey R; Nakhasi HL
    J Immunol; 2018 Jan; 200(1):163-176. PubMed ID: 29187586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with
    Avendaño-Rangel F; Agra-Duarte G; Borba PB; Moitinho V; Avila LT; da Silva LO; Viana SM; Sharma R; Gannavaram S; Nakhasi HL; de Oliveira CI
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against
    Osero BO; Cele Z; Aruleba RT; Maine RA; Ozturk M; Lutz MB; Brombacher F; Hurdayal R
    Front Immunol; 2021; 12():759021. PubMed ID: 35154068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection.
    Satoskar A; Bluethmann H; Alexander J
    Infect Immun; 1995 Dec; 63(12):4894-9. PubMed ID: 7591152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-
    Vellozo NS; Pereira-Marques ST; Cabral-Piccin MP; Filardy AA; Ribeiro-Gomes FL; Rigoni TS; DosReis GA; Lopes MF
    Front Immunol; 2017; 8():1560. PubMed ID: 29204144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrin-Deleted
    Singh RK; Gannavaram S; Ismail N; Kaul A; Gedda MR; Nakhasi HL
    Front Immunol; 2018; 9():1176. PubMed ID: 29915577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response.
    Alexander J; Coombs GH; Mottram JC
    J Immunol; 1998 Dec; 161(12):6794-801. PubMed ID: 9862710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
    Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro indomethacin administration upregulates interleukin-12 production and polarizes the immune response towards a Th1 type in susceptible BALB/c mice infected with Leishmania mexicana.
    Pérez-Santos JL; Talamás-Rohana P
    Parasite Immunol; 2001 Nov; 23(11):599-606. PubMed ID: 11703811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of rapid in vitro co-culture system of macrophages and T-cell subsets to assess the immunogenicity of dogs vaccinated with live attenuated Leishmania donovani centrin deleted parasites (LdCen-/-).
    Viana KF; Fiuza JA; Gannavaram S; Dey R; Selvapandiyan A; Bartholomeu DC; da Silveira-Lemos D; Bueno LL; Dutra WO; Fujiwara RT; Nakhasi HL; Giunchetti RC
    Parasit Vectors; 2016 Apr; 9():250. PubMed ID: 27136900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis.
    Padigel UM; Alexander J; Farrell JP
    J Immunol; 2003 Oct; 171(7):3705-10. PubMed ID: 14500669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular replication-deficient Leishmania donovani induces long lasting protective immunity against visceral leishmaniasis.
    Selvapandiyan A; Dey R; Nylen S; Duncan R; Sacks D; Nakhasi HL
    J Immunol; 2009 Aug; 183(3):1813-20. PubMed ID: 19592661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice.
    Elikaee S; Mohebali M; Rezaei S; Eslami H; Khamesipour A; Keshavarz H; Eshraghian MR
    Vaccine; 2019 May; 37(24):3221-3228. PubMed ID: 31047672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.